ArticleQuantitative imaging in medicine and surgery2021
Clinical characteristics and endovascular treatment in patients with intracranial giant serpentine aneurysms.
Article in Quantitative imaging in medicine and surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Retraction: clinical characteristics and endovascular treatment in patients with intracranial giant serpentine aneurysms.Quantitative imaging in medicine and surgery · 2024Article
- Endovascular occlusion of giant serpentine aneurysm: A case report and literature review.Journal of cerebrovascular and endovascular neurosurgery · 2022Article
- Flow diversion treatment for giant intracranial serpentine aneurysms.Frontiers in aging neuroscience · 2022Article
Corrections and comments
- Retraction · 2024-03-15Euphemisms for Plagiarism · Plagiarism of/in Article ·
- Retracted
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGiant serpentine aneurysms (GSAs) are a rare subtype of intracranial aneurysm. Recently, GSAs have been successfully treated with endovascular parent artery occlusion with or without distal bypass. The present study retrospectively analyzed the clinical outcomes of endovascular parent artery occlusion for intracranial GSAs.
methodsMedical records and cerebral angiograms from our endovascular center were retrospectively analyzed. Twenty-two patients with serpentine aneurysms were treated with endovascular occlusion of the parent artery at the site of the aneurysm. These patients had selective treatment. Clinical and angiographic outcomes of the patients were assessed between the 3-month to 3-year stage.
resultsThe clinical manifestations of GSA included headache, hemiparesis, SAH, epilepsy, memory loss, right oculomotor palsy, and intracerebral hemorrhage. No cerebral infarction occurred. The average Glasgow Outcome Scale (GOS) score was 5. There were no clinical complications and none of the patients had recurrence after selective embolization. All of the patients recovered well, and no recurrence or rebleeding was noted at the follow-up.
conclusionsEndovascular parent artery occlusion may be a safe and effective way to treat intracranial GSAs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.